P4HA3, which participates in collagen biosynthesis, drives tumor progression in ccRCC and colorectal cancer through the PI3K-AKT-GSK3β axis, conversely, its depletion enhances ICI efficacy in breast cancer (46–48). This evidence concerns the gene AKT1 and colorectal cancer.